-The Times of India CHENNAI: Blazing a trail through intricate government and judicial process, gritty transgender K Prithika Yashini has finally realized her dream of donning the uniform of a sub-inspector of police in Tamil Nadu police department. The Madras high court on Thursday declared that she was entitled to be appointed sub-inspector of police. Calling for creation of separate category to accommodate transgenders in employment, the judges further said: "We are...

-Business Standard Since the United Progressive Alliance (UPA) government put a moratorium on commercial cropping of Monsanto's Bt Brinjal in 2010, the Centre has received the first- ever proposal for clearance in five years to let farmers grow a transgenic food crop - a genetically modified hybrid variety of the mustard plant. The decision on the proposal would have to be taken by the environment ministry on behalf of the Union...

-The Times of India LUCKNOW: A scientifically validated anti-diabetes herbal drug, named 'BGR-34', was launched by a Council of Scientific and Industrial Research (CSIR) lab in Lucknow on Sunday. A combination of natural extracts from plants, the drug is based on Ayurveda and has no side effects. The drug is for management of type-II diabetes mellitus. The drug has been jointly developed by two CSIR laboratories, National Botanical Research Institute (NBRI) and...

-DNA The Centre has always claimed that the country has a robust regulatory mechanism Busting the claims of the Indian government and scientists that the country has a robust regulatory mechanism to test genetically modified (GM) crops, toxic loopholes are emerging. From 2008 to 2014, only 39 of the 133 GM crop field trials were properly monitored, leaving the rest for unknown risks and possible health hazards to common people. Documents accessed...

-The Times of India MUMBAI: Certain medicines are being aggressively marketed in India despite inadequate evidence of safety and efficacy, putting patients at risk, said reputed medical journal Lancet. Highlighting weak regulation and monitoring of the domestic drug industry, three recently-introduced medicines are being prescribed and sold though there is a lack of rigorous trials on crucial safety and efficacy parameters. The pharmaceutical industry in India should face the same stringent regulations...